Does Medicare Cover Zepbound for Weight Loss? 2025 Guide
Medicare Coverage for Zepbound
Current Status: Not Covered for Weight Loss Only
Zepbound is not covered by Medicare Part D when prescribed solely for weight management.
Zepbound (tirzepatide) received FDA approval in November 2023 for weight management. However, like Wegovy, it falls under the Medicare statutory exclusion for drugs used for weight loss purposes. Mounjaro (same molecule for diabetes) may be covered under Part D for eligible diabetes patients.
What About Mounjaro?
Mounjaro (tirzepatide for diabetes) may be covered under Medicare Part D plans if you have type 2 diabetes. Coverage depends on your plan's formulary and prior authorization requirements.